Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Expression changes of Tim-3 as one of supplementary indicators for monitoring prognosis of liver pathological changes in chronic HBV infection

Fig. 2

Tim-3 level in CHB patients with different prognosis condition after antiviral therapy before and after 12-month follow-up. A The levels of Tim-3 grouped according to pathological changes of liver tissues with stable condition, improved condition and progression condition. B Tim-3 ratio at 12-month follow-up level to that of baseline level in patients who were grouped according to pathological changes of liver tissue. *P < 0.05; **P < 0.01

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us